We’re in the midst of a paradigm shift in biomarker science. | The right biomarker signature can de-risk trials, guide ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Gayle Hamilton, director of RBQM for IQVIA’s Digital Trial Management Suite, is an experienced Risk-Based Monitoring project advisor and project lead, with a strong background in clinical ...

StudyFormycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206 10.07.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Data from NPC and CEVR reveal utilization management is common even when clinical guidelines do not support its use. WASHINGTON, DC, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- New research by ...

Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. In the ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Patients with inflammatory bowel disease may be twice as likely to develop rheumatoid arthritis than those without IBD.

MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader, and ZeOmega®, the leading population health management organization, today announced ...